LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study is a research paper published in Molecular Therapy — Methods & Clinical Development (2022). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: ES030285
National Institutes of Health
Grant: U42OD026645
National Institutes of Health
Grant: CA125123
National Institutes of Health
Grant: T32HL07676
National Institutes of Health
Grant: R01HL152314
National Institutes of Health
Grant: UG3HL151545
National Institutes of Health
Grant: R01HL132840
National Institutes of Health
Grant: R01DK124477
National Institutes of Health
Grant: DK56338
Heart and Stroke Foundation of Canada
Grant: G-17-0018740
Cancer Prevention and Research Institute of Texas
Grant: RP170719
Cancer Prevention and Research Institute of Texas
Grant: RP150578
American Heart Association Inc
Grant: 19POST34430092
American Heart Association Inc
Grant: 19PRE34380467
Canadian Institutes of Health Research
Grant: PG-45375
Natural Sciences and Engineering Research Council of Canada
Grant: RGPIN-2015-05006
NCI NIH HHS
Grant: P30 CA125123
NIDDK NIH HHS
Grant: P30 DK056338
NIEHS NIH HHS
Grant: P30 ES030285
NHLBI NIH HHS
Grant: T32 HL007676
National Institutes of Health
Grant: 5P30DK056338-18
Texas Medical Center Digestive Diseases Center
Natural Sciences and Engineering Research Council of Canada
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01HL152314-04
HBB gene-editing for treating sickle cell disease
National Institutes of Health
Grant: 5T32HL007676-18
Molecular Excitability in the Cardiovascular System
National Institutes of Health
Grant: 1U42OD026645-01
BCM-Rice resource for the analysis of somatic gene editing in mice
National Institutes of Health
Grant: 1R01DK124477-01
Physiological Dissection of the Mevalonate Pathway
National Institutes of Health
Grant: 2R01HL132840-06
Genetic Repair of Familial Hypercholesterolemia
National Institutes of Health
Grant: 5UG3HL151545-02
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity
FWCI
2.26
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study
LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study